Urea

A small carbamide molecule (60 Da) that occupies a uniquely dual cosmetic position — humectant at low concentrations, keratolytic at high concentrations, with the inflection point around 10%. At sub-10% it integrates into stratum-corneum NMF (urea is a native component), binds water through its amide groups, and modestly increases penetration of co-formulated actives via stratum-corneum hydration. At 10–40% it disrupts hydrogen bonding in stratum-corneum protein keratin, dissolving hyperkeratotic plugs in keratosis pilaris, callus, and psoriatic plaques. The same molecule, two distinct pharmacologies, distinguished only by dose — rare and worth attending to.

2–10% (humectant, face); 10–40% (keratolytic, body)

Body: 10–40% for KP and callus; face: 2–10% for hydration. pH-sensitive — alkaline conditions cause hydrolysis to ammonia (off-smell, irritation); urea formulations need acidic buffering. Pairs with lactic acid for body, ceramides for face.

High-dose urea (>20%) stings broken or eczema-active skin; low-dose is fine. Confused with 'urine' in marketing folklore — modern urea is synthesized.

pH stability is a real and under-disclosed formulation issue: in alkaline conditions urea hydrolyses to ammonia, producing both off-smell and irritation — properly buffered formulations are stable but lower-tier products genuinely degrade. The 'urea = urine' folkloric association persists in consumer perception despite modern urea being synthesised from ammonia and CO₂. High-dose urea (>20%) genuinely stings broken or eczema-active skin; low-dose is tolerated by virtually everyone.

The Eucerin-and-Aquaphor European-dermatology staple having a clean-aware renaissance via The Inkey List Urea Cream and the broader 'German skincare minimalism' moment of 2024–2025. The molecule earns the comeback — it is genuinely one of the most versatile and well-evidenced actives on the body-care shelf, and the keratolytic-at-high-dose pharmacology is underused in mainstream face care.